[Pediatric inpatient interdisciplinary multimodal pain treatment in Germany].

Severely disabling chronic pain affects approximately half a million children in Germany. If there is a lack of response to unimodal treatment, an inpatient interdisciplinary multimodal pain treatment (IMPT) can be considered. This review article describes the supply situation of pediatric inpatient IMPT in Germany and presents the current evidence on the effectiveness. Based on a systematic literature search, studies addressing the effectiveness of pediatric inpatient IMPT in Germany were identified. In addition, further sources were used to extract information on pediatric IMPT treatment centers in Germany in order to describe the treatment approaches, the qualification of personnel and characteristics of patients. There are four pediatric pain centers in Germany that are specialized in inpatient IMPT for children and adolescents. Treatment duration ranges between 3 and 4 weeks. The multimodal treatment is carried out by a multiprofessional team and is generally available for patients up to 18 years. The majority of patients are female. The effectiveness of pediatric IMPT in Germany was investigated up to 4 years after treatment. Positive effects were shown for pain characteristics and also for the emotional burden. Additional treatment modules can facilitate further optimization of treatment effects. Further research on the effectiveness of IMPT in Germany is important in order to refine and optimize the available treatment programs.

Wager J ，Zernikow B 《-》

[Therapy recommendations in a pediatric outpatient pain clinic : Adherence and effectiveness of implementation].

Barth F ，Wager J ，Hübner-Möhler B ，Zernikow B ... -  《-》

[Cross-sectoral interdisciplinary multimodal pain therapy : Recommendations on structural and process parameters of the ad hoc commission "Interdisciplinary Multimodal Pain Therapy" of the German Pain Society (Deutsche Schmerzgesellschaft e.  V.)].

Pfingsten M ，Arnold B ，Böger A ，Brinkschmidt T ，Casser HR ，Irnich D ，Kaiser U ，Klimczyk K ，Lutz J ，Schiltenwolf M ，Seeger D ，Zernikow B ，Sabatowski R ... -  《-》

[Tetrahydrocannabinol (THC) in patients with fibromyalgia syndrome (FMS) : A retrospective study of changes in pain, psychometric variables, and analgesic consumption during inpatient interdisciplinary multimodal pain therapy (IMPT)].

Since March 1, 2017, medical cannabis (MC) can be prescribed nationwide in Germany. To date, there have been a number of qualitatively different studies on the effectiveness of MC in fibromyalgia syndrome (FMS). The aim of the study was to investigate the effectiveness of THC in the course of interdisciplinary multimodal pain therapy (IMPT) on pain and several psychometric variables. For the study, in the period 2017-2018, all patients in the pain ward of a clinic who were suffering from FMS and were treated in a multimodal interdisciplinary setting were selected based on inclusion criteria. The patients were examined separately according to groups with and without THC about pain intensity, various psychometric parameters and analgesic consumption during the stay. Of the 120 FMS patients included in the study, 62 patients (51.7%) were treated with THC. In the parameters of pain intensity, depression, and quality of life, there was a significant improvement in the entire group during the stay (p < 0.001), which was significantly greater through the use of THC. In five of the seven analgesic groups examined, the dose was reduced or the drug discontinued significantly more often in the patients treated with THC. The results provide indications that THC can be considered as a medical alternative in addition to the substances previously recommended in various guidelines.

Bettstetter H ，Schäfer A 《-》

[Multimodal pain therapy for treatment of chronic pain syndrome. Consensus paper of the ad hoc commission on multimodal interdisciplinary pain management of the German Pain Society on treatment contents].

Arnold B ，Brinkschmidt T ，Casser HR ，Diezemann A ，Gralow I ，Irnich D ，Kaiser U ，Klasen B ，Klimczyk K ，Lutz J ，Nagel B ，Pfingsten M ，Sabatowski R ，Schesser R ，Schiltenwolf M ，Seeger D ，Söllner W ... -  《-》